RSS   Newsletter   Contact   Advertise with us
Post Online Media

Regulus names VP, investor relations & corporate communications

Allison WeyRegulus Therapeutics Inc., a biopharmaceutical company, announced that Allison Wey has been appointed vice president, investor relations and corporate communications.
Article continues below

READ MORE Unigene Laboratories: Jenene D. Thomas new vice president

Ms. Wey brings over 25 years of experience in investor relations, corporate communications, media relations and investment banking.

Prior to joining Regulus, Ms. Wey was Vice President, Investor Relations for Durata Therapeutics up until its acquisition by Actavis. Before Durata, Ms. Wey served as Vice President, Investor Relations and Corporate Affairs at Par Pharmaceuticals from 2007 until its acquisition by TPG.

Ms. Wey also has extensive experience in media relations and corporate communications including working as VP, Investor Relations at Boron, LePore & Associates, Senior VP at Edelman Financial Worldwide, Managing Director, Financial Communications at Hill & Knowlton, and Associate Director, Equity Capital Markets at Bear, Stearns & Co. Inc..



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy